Theoretical and Natural Science
- The Open Access Proceedings Series for Conferences
Theoretical and Natural Science
Vol. 17, 04 December 2023
Open
Access | Article
Pancreatic diseases, treatments, and emerging therapeutic strategies: A comprehensive overview
* Author to whom correspondence should be addressed.
Abstract
The pancreas is one of the key organs in the human body, it will lead to some diseases. This passage will introduce the location, the function and some basic information about the pancreas. Pancreatitis can have some bad effects; it triggers the immune system's defense mechanism. The cause of pancreatitis can be excessive drinking and smoking. Pancreatitis is associated with blurred vision and other symptoms. Pancreatic cancer is the most dangerous cancers in the world, and scientists don't know what causes it, but they have some theories about why. Including genetic mutations and other causes. Pancreatic cancer has some methods that can inhibit it, including operation, radiation therapy. Chemotherapy and targeted therapy are also very common methods. Total pancreatectomy, pancreaticoduodenectomy are very common. Also important is the metastasis of pancreatic cancer, which makes patients sicker, and FOLFIRINOX and immunotherapy are the main treatments. The mRNA vaccine is currently in the research and development stage, and it is relatively useful to synthesize the vaccine using uridine mRNA-liposome nanoparticle technology and combine with drug treatment. However, many technologies are not perfect at present, such as early inspection technology and surgery, and I hope that scientists can find better solutions in the future.
Keywords
Pancreas, Pancreatitis, Pancreatic Cancer
References
1. Garg SK, Sarvepalli S, Campbell JP, et al. Incidence, admission rates, and predictors, and economic burden of adult emergency visits for acute pancreatitis. J Clin Gastroenterol. 2019;53(3):220-225.
2. Pancreatic cancer diagnosis and treatment code (2018) [J]. Chin J Clin Hepatol, 2019,35(02):281-293. Study on prevention and control strategy of pancreatic cancer[J]. Chin J Prev Med, 2013(07):581-585.
3. Sedano J, Swamy R, Jain K, Gupta S. Brunner's gland hamartoma of the duodenum. Ann R Coll Surg Engl. 2015;97(5):e70-e72. Accessed 5/6/2022.
4. Pancreas Foundation. Common Disorders of the Pancreas. Accessed 10/1/2021.
5. Radulova-Mauersberger, O., Belyaev, O., Birgin, E., Bösch, F., Brunner, M., Müller-Debus, C. F., … Witzigmann, H. (2020). Indications for Surgical and Interventional Therapy of Acute Pancreatitis. Zentralblatt Fur Chirurgie - Zeitschrift Fur Allgemeine, Viszeral- Und Gefasschirurgie, 145(4), 374–382.
6. Chen, W. Y. , Garber, J. E. , Higham, S. , Schneider, K. A. , & Li, F. P. . (2002). Brca1/2 genetic testing in the community setting. Journal of Clinical Oncology, 20(22), 4485-4492
7. Zhai S , Huo Z , Wang Y ,et al.TRIANGLE operation for borderline resectable pancreatic cancer in total pancreatectomy[J].Translational Cancer Research, 2019(6).DOI:10.21037 /tcr.2019.09.50.
8. Waldman AD, Fritz JM, Lenardo MJ. A guide to cancer immunotherapy: From T cell basic science to clinical practice. Nat Rev Immunol (2020) 20(11):651–68. doi: 10.1038/s41577-020-0306-5.
9. Rojas, L. A., Sethna, Z., Soares, K. C., Olcese, C., Pang, N., Patterson, E., … Balachandran, V. P. (2023). the Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer. Nature, 618(7963), 144–150.
10. Tan S, Li D, Zhu X. Cancer immunotherapy: Pros, cons and beyond. BioMed Pharmacother (2020) 124:109821. doi: 10.1016/j.biopha.2020.109821.
Data Availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).
- Volume Title
- Proceedings of the 2nd International Conference on Modern Medicine and Global Health
- ISBN (Print)
- 978-1-83558-197-1
- ISBN (Online)
- 978-1-83558-198-8
- Published Date
- 04 December 2023
- Series
- Theoretical and Natural Science
- ISSN (Print)
- 2753-8818
- ISSN (Online)
- 2753-8826
- DOI
- 10.54254/2753-8818/17/20240641
- Copyright
- 04 December 2023
- Open Access
- This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited